TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00563784 · COMPLETED
Trial details
- NCT number
- NCT00563784
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2018-05-30
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.